Teleflex (NYSE:TFX) Sets New 52-Week Low - What's Next?

Teleflex Incorporated (NYSE:TFX - Get Free Report) shares hit a new 52-week low during trading on Monday . The stock traded as low as $116.60 and last traded at $117.80, with a volume of 1263650 shares traded. The stock had previously closed at $117.72.

Analyst Upgrades and Downgrades

TFX has been the topic of several research reports. Truist Financial reduced their price target on shares of Teleflex from $140.00 to $137.00 and set a "hold" rating on the stock in a research report on Monday, May 5th. Wells Fargo & Company reduced their price objective on Teleflex from $146.00 to $137.00 and set an "equal weight" rating on the stock in a report on Friday, May 2nd. Mizuho set a $155.00 target price on Teleflex in a research report on Wednesday, April 16th. Citizens Jmp cut Teleflex from an "outperform" rating to a "market perform" rating in a report on Thursday, February 27th. Finally, Raymond James Financial cut Teleflex from an "outperform" rating to a "market perform" rating in a report on Friday, February 28th. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, Teleflex currently has an average rating of "Hold" and a consensus price target of $164.63.

Teleflex Price Performance

The company has a current ratio of 2.28, a quick ratio of 1.32 and a debt-to-equity ratio of 0.44. The company has a fifty day moving average price of $125.44 and a two-hundred day moving average price of $149.63. The firm has a market cap of $5.22 billion, a P/E ratio of 37.26, a PEG ratio of 1.85 and a beta of 1.10.

Teleflex (NYSE:TFX - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The medical technology company reported $2.91 earnings per share for the quarter, beating analysts' consensus estimates of $2.88 by $0.03. The firm had revenue of $700.67 million for the quarter, compared to analyst estimates of $699.37 million. Teleflex had a net margin of 4.96% and a return on equity of 14.73%. The business's revenue was down 5.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $3.21 earnings per share. Equities analysts anticipate that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, June 16th. Stockholders of record on Tuesday, May 20th were paid a dividend of $0.34 per share. The ex-dividend date of this dividend was Tuesday, May 20th. This represents a $1.36 annualized dividend and a dividend yield of 1.15%. Teleflex's dividend payout ratio is currently 42.90%.

Institutional Investors Weigh In On Teleflex

Several large investors have recently made changes to their positions in TFX. Sanctuary Advisors LLC boosted its holdings in shares of Teleflex by 28.2% during the fourth quarter. Sanctuary Advisors LLC now owns 6,251 shares of the medical technology company's stock worth $1,143,000 after acquiring an additional 1,374 shares during the period. Ieq Capital LLC increased its stake in shares of Teleflex by 178.2% in the 4th quarter. Ieq Capital LLC now owns 12,890 shares of the medical technology company's stock valued at $2,294,000 after purchasing an additional 8,257 shares during the last quarter. Olympiad Research LP acquired a new position in Teleflex during the fourth quarter worth about $219,000. Fjarde AP Fonden Fourth Swedish National Pension Fund lifted its stake in Teleflex by 43.0% in the 4th quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 11,644 shares of the medical technology company's stock valued at $2,072,000 after purchasing an additional 3,500 shares during the last quarter. Finally, South Dakota Investment Council boosted its holdings in shares of Teleflex by 16.4% during the 4th quarter. South Dakota Investment Council now owns 9,230 shares of the medical technology company's stock valued at $1,643,000 after acquiring an additional 1,300 shares in the last quarter. Institutional investors and hedge funds own 95.62% of the company's stock.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.